These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Advances in understanding of pathogenesis of aHUS and HELLP. Fang CJ; Richards A; Liszewski MK; Kavanagh D; Atkinson JP Br J Haematol; 2008 Nov; 143(3):336-48. PubMed ID: 18691170 [TBL] [Abstract][Full Text] [Related]
26. The decay accelerating factor mutation I197V found in hemolytic uraemic syndrome does not impair complement regulation. Kavanagh D; Burgess R; Spitzer D; Richards A; Diaz-Torres ML; Goodship JA; Hourcade DE; Atkinson JP; Goodship TH Mol Immunol; 2007 May; 44(12):3162-7. PubMed ID: 17368771 [TBL] [Abstract][Full Text] [Related]
27. [Prognosis of the hemolytic-uremic syndrome]. Vermeer BJ; Troelstra JA; Elema JD Ned Tijdschr Geneeskd; 1972 Apr; 116(18):731-6. PubMed ID: 5019659 [No Abstract] [Full Text] [Related]
28. Kidney transplantation in atypical haemolytic uraemic syndrome (aHUS): a cheap way out? Bemelman FJ; ten Berge IJ Neth J Med; 2013 Sep; 71(7):339-41. PubMed ID: 24038558 [No Abstract] [Full Text] [Related]
29. A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor I in complement regulation. Nilsson SC; Karpman D; Vaziri-Sani F; Kristoffersson AC; Salomon R; Provot F; Fremeaux-Bacchi V; Trouw LA; Blom AM Mol Immunol; 2007 Mar; 44(8):1835-44. PubMed ID: 17084897 [TBL] [Abstract][Full Text] [Related]
30. Successful pre-transplant management of a patient with anti-factor H autoantibodies-associated haemolytic uraemic syndrome. Kwon T; Dragon-Durey MA; Macher MA; Baudouin V; Maisin A; Peuchmaur M; Fremeaux-Bacchi V; Loirat C Nephrol Dial Transplant; 2008 Jun; 23(6):2088-90. PubMed ID: 18326881 [No Abstract] [Full Text] [Related]
31. [Familial and recurrent hemolytic-uremic syndrome: apropos a case]. Barriuso Lapresa LM; Nadal Lizabe I; del Moral Aldaz JM An Esp Pediatr; 1996 Feb; 44(2):167-9. PubMed ID: 8830580 [No Abstract] [Full Text] [Related]
33. Mutations in proteins of the alternative pathway of complement and the pathogenesis of atypical hemolytic uremic syndrome. Abarrategui-Garrido C; Melgosa M; Peña-Carrión A; de Jorge EG; de Córdoba SR; López-Trascasa M; Sánchez-Corral P Am J Kidney Dis; 2008 Jul; 52(1):171-80. PubMed ID: 18423815 [TBL] [Abstract][Full Text] [Related]
34. Complement hyperactivation may cause atypical haemolytic uraemic syndrome--gain-of-function mutations in factor B. Caprioli J; Remuzzi G Nephrol Dial Transplant; 2007 Sep; 22(9):2452-4. PubMed ID: 17510099 [No Abstract] [Full Text] [Related]